 Writing in Forbes Online, John Goodman says personalized medicine is the future. It's where science is going, he says, and it's where technology is going, where doctors and patients will likely want to go. Yet, unfortunately, for many of us, Goodman says, this is not where the Obama administration wants to go. The good news? Well, things like biosensors that can be worn on clothing or jewelry held against the skin by a band-aid-like patch or inserted beneath the skin, these are now capable of monitoring a whole host of chronic diseases. The science of genetics is about to explode. As many as 1,300 genetic tests are currently available that relate to some 2,500 medical conditions. In the area of gene therapy, progress has been slow, but in some cases remarkable. There's now a genetic test that can determine with uncanny accuracy whether a patient's eye cancer is curable or fatal. But now for the bad news. In an interview with CNN the other day, former White House health adviser Ezekiel Emanuel called personalized medicine a myth. But if custom-made suits fit better and look better, Goodman says, what's wrong with that? Ditto for healthcare. The answer is, Obama cares entire approach to cost control as premised on the idea we're all alike. And if we aren't alike, everything they are doing doesn't make sense. You'll want to read Goodman's column online. We've made it easy for you. Subscribe to our daily RSS feed by pointing your web browser to kidneycancer.org. Scroll down and look for the link for the RSS feed. Or better yet, join the conversation on Facebook at facebook.com slash us.health.care. There you'll be able to weigh in with your opinion on health care reform. And you'll also find the link to personalized health care choice versus government-mandated Obamacare. John C. Goodman is president and Kelly Wright fellow in health care at the National Center for Policy Analysis, Dallas, Texas, and is a research fellow at the Independent Institute Oakland, California, and author most recently of Priceless, Curing the Health Care Crisis. His article is copyrighted and appears in Forbes online.